
Indrayani Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-08-19 08:00:27Indrayani Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a previously risky profile to one that now appears attractive based on key metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite ongoing operational challenges and a micro-cap status, this revaluation invites a closer examination of the company’s price attractiveness relative to its historical performance and peer group within the Other Agricultural Products sector.
Read full news article
Indrayani Biotech Ltd is Rated Strong Sell
2026-08-18 10:10:22Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleWhen is the next results date for Indrayani Biotech Ltd?
2026-08-13 23:16:51The next results date for Indrayani Biotech Ltd is scheduled for 17 August 2026....
Read full news article
Indrayani Biotech Ltd is Rated Strong Sell
2026-08-04 10:10:44Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 04 August 2026, providing investors with the latest comprehensive analysis.
Read full news article
Indrayani Biotech Ltd is Rated Strong Sell
2026-07-21 10:10:29Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Indrayani Biotech Ltd is Rated Strong Sell
2026-07-09 10:10:26Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, but the analysis and financial metrics presented here reflect the stock’s current position as of 09 July 2026.
Read full news article
Indrayani Biotech Ltd is Rated Strong Sell
2026-06-28 10:10:18Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 June 2026, providing investors with an up-to-date view of its performance and outlook.
Read full news article
Indrayani Biotech Ltd is Rated Strong Sell
2026-06-16 10:11:10Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Indrayani Biotech Ltd is Rated Strong Sell
2026-06-05 10:10:20Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
20-Aug-2026 | Source : BSENews paper Publication of audited financials results (Standalone & Consolidated) for quarter and year ended March 31 2026.
Result-Audited Financial Results For Quarter And Year Ended March 31 2026 Along With Report Of Statutory Auditor.
19-Aug-2026 | Source : BSEAudited financial results for quarter and year ended March 31 2026 along with report of statutory auditors.
Results-Delay in Financial Results
17-Aug-2026 | Source : BSEAudited Standalone & Consolidated financial results for the quarter and year ended March 31 2026 along with auditors report.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Indrayani Biotech Ltd has announced 5:7 rights issue, ex-date: 28 Apr 26






